Data in support of proteomic analysis of pneumococcal pediatric clinical isolates to construct a protein array

Alfonso Olaya-Abril1, Ignacio Obando2, Manuel J Rodríguez-Ortega1

  • 1Departamento de Bioquímica y Biología Molecular, Universidad de Córdoba, Campus de Excelencia Internacional CeiA3, Córdoba, Spain.

Data in Brief
|March 8, 2016
PubMed

Insights

This study identified novel surface proteins of Streptococcus pneumoniae, a leading cause of child mortality. These proteins show potential as targets for new vaccines and affordable diagnostic tools for early infection detection.

Area of Science:

  • Microbiology
  • Proteomics
  • Immunology

Background:

  • Surface proteins are crucial for microbial interactions and are key targets for therapeutic and diagnostic development.
  • Streptococcus pneumoniae is a significant pediatric pathogen causing over 1.5 million child deaths globally.
  • Serodiagnostic tools offer affordable methods for early infection diagnosis.

Purpose of the Study:

  • To identify potential surface protein targets from Streptococcus pneumoniae for vaccine and diagnostic development.
  • To explore the serological reactivity of identified surface proteins using patient sera.

Main Methods:

  • Proteomic analysis of pediatric clinical isolates of Streptococcus pneumoniae using trypsin shaving and LC/MS/MS.
  • Production of 95 selected proteins as recombinant polypeptides for array printing.
  • Probing of the protein array with patient sera to identify serodiagnostic antigens.

Main Results:

  • Identification of 95 candidate surface proteins from Streptococcus pneumoniae.
  • Demonstration of serological reactivity for several identified proteins using patient sera.
  • Data deposited in the ProteomeXchange Consortium (PXD001740).

Conclusions:

  • Surface proteins of Streptococcus pneumoniae are promising candidates for vaccine and diagnostic development.
  • The identified antigens can be utilized for creating affordable serodiagnostic tools for early infection detection.
  • This research contributes to the development of novel strategies against a major pediatric pathogen.